SIC
Starr International Company Portfolio holdings
AUM
$19.9M
This Quarter Return
+33.25%
1 Year Return
-39.69%
3 Year Return
-26.08%
5 Year Return
-43.79%
10 Year Return
-39.24%
AUM
$49.8M
AUM Growth
+$49.8M
(+26%)
Cap. Flow
+$143K
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Bain Capital Specialty
BCSF
|
$143K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 69.43% |
| 2 | Financials | 30.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $25.8M | 51.74% | 67,000 | – | – |
|
|
2
Bain Capital Specialty
BCSF
$1.03B
| $11.8M | 23.66% | 794,543 +9,653 | +1% | +$143K |
|
3
AstraZeneca
AZN
$248B
| $5.59M | 11.21% | 93,000 | – | – |
|
4
American International
AIG
$45.1B
| $3.45M | 6.91% | 62,788 | – | – |
|
5
Johnson & Johnson
JNJ
$427B
| $3.23M | 6.48% | 20,000 | – | – |
|